Rxo (RXO) Profit After Tax (2021 - 2025)
Rxo (RXO) has disclosed Profit After Tax for 5 consecutive years, with -$46.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Profit After Tax fell 84.0% year-over-year to -$46.0 million, compared with a TTM value of -$100.0 million through Dec 2025, up 65.52%, and an annual FY2025 reading of -$100.0 million, up 65.52% over the prior year.
- Profit After Tax was -$46.0 million for Q4 2025 at Rxo, down from -$14.0 million in the prior quarter.
- Across five years, Profit After Tax topped out at $44.0 million in Q2 2022 and bottomed at -$243.0 million in Q3 2024.
- Average Profit After Tax over 5 years is -$15.8 million, with a median of -$5.5 million recorded in 2022.
- The sharpest move saw Profit After Tax skyrocketed 150.0% in 2023, then tumbled 24200.0% in 2024.
- Year by year, Profit After Tax stood at $42.0 million in 2021, then plummeted by 109.52% to -$4.0 million in 2022, then surged by 150.0% to $2.0 million in 2023, then crashed by 1350.0% to -$25.0 million in 2024, then tumbled by 84.0% to -$46.0 million in 2025.
- Business Quant data shows Profit After Tax for RXO at -$46.0 million in Q4 2025, -$14.0 million in Q3 2025, and -$9.0 million in Q2 2025.